SCHEMBL26106568

SCHEMBL26106568

C=CC(=O)N1CCN(c2nccnc2-c2cccc(C(F)(F)F)c2)CC1

nearest known ligand 0.51

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ SLC6A7 Q99884 1/20 0.51
▸ EGFR P00533 1/20 0.48
▸ ITK Q08881 1/20 0.48
▸ TRPA1 O75762 2/20 0.48
▸ TRPV1 Q8NER1 1/20 0.48
▸ LMNA P02545 4/20 0.47
▸ MAPK1 P28482 1/20 0.47
▸ RAB9A P51151 1/20 0.47
▸ TEAD1 P28347 3/20 0.44
▸ ALDH1A1 P00352 3/20 0.43
▸ HPGD P15428 2/20 0.43
▸ ABL1 P00519 1/20 0.43
▸ BCR P11274 1/20 0.43
▸ MEN1 O00255 1/20 0.43
▸ KMT2A Q03164 1/20 0.43
▸ TP53 P04637 1/20 0.43
▸ SMN1; SMN2 Q16637 1/20 0.43
▸ KDM4E B2RXH2 2/20 0.42
▸ CYP2C9 P11712 1/20 0.42
▸ CYP2C19 P33261 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30591895 1.00 SLC6A7 (0.51) SLC6A7EGFRITKTRPA1TRPV1
SCHEMBL30591592 0.86 SLC6A7 (0.48) SLC6A7EGFRITKTRPA1TRPV1
SCHEMBL26104597 0.86 SLC6A7 (0.48) SLC6A7EGFRITKTRPA1TRPV1
SCHEMBL26107736 0.81 EGFR (0.52) EGFRTRPA1TRPV1LMNAALDH1A1
SCHEMBL30591789 0.81 EGFR (0.52) EGFRTRPA1TRPV1LMNAALDH1A1
SCHEMBL26106903 0.78 PDE10A (0.42) SLC6A7TRPA1TRPV1LMNAALDH1A1
SCHEMBL25787571 0.77 LMNA (0.68) LMNAMAPK1RAB9AALDH1A1HPGD
Hydrochloric Acid SCHEMBL3322312 0.76 MAPT (0.57) ALDH1A1HPGDKDM4EMAPTNPSR1
SCHEMBL30591611 0.74 SLC6A7 (0.46) SLC6A7TRPA1TRPV1TEAD1ABL1
SCHEMBL30591874 0.74 TRPV1 (0.52) TRPA1TRPV1TEAD1SMN1; SMN2CYP2C9

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20250206722-A1 SMALL MOLECULE INHIBITORS OF TEA DOMAIN FAMILY MEMBERS THE SCRIPPS RESEARCH INSTITUTE 2025-06-26 — — US claimed
WO-2023183768-A2 SMALL MOLECULE INHIBITORS OF TEA DOMAIN FAMILY MEMBERS THE SCRIPPS RESEARCH INSTITUTE (US) 2023-09-28 — — WO claimed
US-20250206722-A1 SMALL MOLECULE INHIBITORS OF TEA DOMAIN FAMILY MEMBERS THE SCRIPPS RESEARCH INSTITUTE 2025-06-26 — — US disclosed
WO-2023183768-A2 SMALL MOLECULE INHIBITORS OF TEA DOMAIN FAMILY MEMBERS THE SCRIPPS RESEARCH INSTITUTE (US) 2023-09-28 — — WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20250206722-A1 SMALL MOLECULE INHIBITORS OF TEA DOMAIN FAMILY MEMBERS YAP1, TEAD1, TEAD2 SLC6A7 2221/4885EGFR 789/4885ITK 4029/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback